Genes and patent policy: rethinking intellectual property rights
- 1 October 2002
- journal article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 3 (10) , 803-808
- https://doi.org/10.1038/nrg909
Abstract
Concerns about human gene patents go beyond moral disquiet about creating a commodity from a part of the human body and also beyond legal questions about whether genes are unpatentable products of nature. New concerns are being raised about harm to public health and to research. In response to these concerns, various policy options, such as litigation, legislation, patent pools and compulsory licensing, are being explored to ensure that gene patents do not impede the practice of medicine and scientific progress.Keywords
This publication has 12 references indexed in Scilit:
- Diagnostic testing fails the testNature, 2002
- French Challenge to BRCA1 Patent Underlies European DiscontentJNCI Journal of the National Cancer Institute, 2002
- French researchers take a stand against cancer gene patentNature, 2001
- Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencingJournal of Medical Genetics, 2001
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience, 1998
- The Patenting of DNAScience, 1998
- Whose DNA Is It, Anyway?Science, 1997
- Religion and Gene PatentingScience, 1995
- Theory, Practice, and Poetry in VicoPublished by Walter de Gruyter GmbH ,1980
- ST. MARY'S HOSPITAL.: Sporadic Cholera; Death; AutopsyThe Lancet, 1853